These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8458616)

  • 21. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    Maffioli P; Fogari E; D'Angelo A; Perrone T; Derosa G
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of glyburide therapy on lipoproteins in non-insulin-dependent diabetes mellitus.
    Hughes TA; Kramer JO; Segrest JP
    Am J Med; 1985 Sep; 79(3B):86-91. PubMed ID: 3931466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Brunner D
    Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
    Chen YD; Swami S; Skowronski R; Coulston A; Reaven GM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
    Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ
    Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes.
    Uusitupa M; Södervik H; Silvasti M; Karttunen P
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):153-7. PubMed ID: 2110937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of glibenclamide therapy on carbohydrate and lipid metabolism and insulin secretion in patients with glucose tolerance disorders : a 5-year study].
    Ratzmann KP; Witt S; Schulz B; Jahr D; Heinke P
    Z Gesamte Inn Med; 1981 Dec; 36(23):913-7. PubMed ID: 6805141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
    Ruge T; Sukonina V; Kroupa O; Makoveichuk E; Lundgren M; Svensson MK; Olivecrona G; Eriksson JW
    Metabolism; 2012 May; 61(5):652-60. PubMed ID: 22078753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of alpha-glucosidase inhibitor in combination with sulphonylurea compounds on lipid profile in patients with non-insulin-dependent diabetes mellitus.
    Okada S; Ishii K; Tanokuchi S; Hamada H; Ichiki K; Ota Z
    J Int Med Res; 1995; 23(6):492-6. PubMed ID: 8746618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load.
    Derosa G; Cicero AF; Fogari E; D'Angelo A; Bianchi L; Maffioli P
    Horm Metab Res; 2011 Jun; 43(7):505-12. PubMed ID: 21590648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels.
    Cominacini L; Garbin U; Davoli A; Campagnola M; De Santis A; Pasini C; Pastorino AM; Bosello O
    Ann Nutr Metab; 1993; 37(4):175-84. PubMed ID: 8215234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of Staub Effect and amelioration of insulin secretion defects after glyburide treatment in non-insulin-dependent diabetes.
    Soneru IL; Hein N; Jeffery JD; Abraira C
    Diabetes Res; 1990 Oct; 15(2):77-83. PubMed ID: 2132401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.
    Kyllästinen M; Groop L
    Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of glibenclamide treatment on insulin secretion and on insulin binding to erythrocytes in type II diabetes mellitus.
    Araujo LM; Ursich MJ; Pupo AA; Fukui RT
    Braz J Med Biol Res; 1988; 21(1):35-42. PubMed ID: 3140992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance.
    Ratzmann KP; Witt S; Schulz B
    Diabete Metab; 1983; 9(2):87-93. PubMed ID: 6413265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of treatment of the concentration of lipoproteins and the postheparin-lipolytic activity in the plasma of noninsulin-dependent diabetics.
    Breier C; Lisch HJ; Sailer S
    Klin Wochenschr; 1982 Jun; 60(11):551-4. PubMed ID: 6810015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperglycaemic clamp and insulin binding to isolated monocytes before and after glibenclamide treatment of mild type II diabetics.
    Pagano G; Lombardi A; Pisu E; Bozzo C; Masciola P; Ferraris GM; Bruno A
    Horm Metab Res; 1984 May; 16(5):215-20. PubMed ID: 6429023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.